Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 4:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 1,638 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: One MORE Clear all

Conditions: Atrial Arrhythmia, Atrium; Fibrillation, Atrial Tachycardia
Interventions: electrophysiology study and ablation with an Abbott Ablation Catheter; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: Not listed
Enrollment: 200 participants
Timeline: 2022 – 2026
U.S. locations: 20
States / cities: Huntsville, Alabama • Little Rock, Arkansas • Rancho Mirage, California + 16 more

Conditions: Diabetes Mellitus
Interventions: Exubera, Randomized diabetes therapy; Drug · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 7,439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 131
States / cities: Bay Minette, Alabama • Graysville, Alabama • Pell City, Alabama + 111 more

Conditions: Atrophy
Interventions: CaHMB (Dietary supplement, not Drug), CaLa; Drug · Dietary Supplement
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Embryonal Tumor With Multilayered Rosettes, Embryonal Tumor With Multilayered Rosettes, Nos
Interventions: Radiotherapy (RT), Chemotherapy Drug, Cancer - Physician's Choice, Non-Investigational Surgical Resection, Temozolomide, Tumor Tissue Sample, Blood Sample, Cerebrospinal Fluid (CSF) Sample; Radiation · Drug · Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 8
States / cities: Birmingham, Alabama • San Francisco, California • Indianapolis, Indiana + 5 more

Conditions: Advanced Cancer, Advanced Solid Tumor, Melanoma, Metastasis, Pleural Mesothelioma, Renal Cell Carcinoma, MSI-High, Mismatch Repair Deficiency, Colorectal Cancer, Hepatocellular Carcinoma, Hepatocellular Cancer, Renal Cell Cancer, Kidney Cancer, Skin Cancer, Non Small Cell Lung Cancer, NSCLC, Anaplastic Lymphoma Kinase Genomic Tumor Aberrations, ALK Genomic Tumor Aberrations
Interventions: Alintegimod, Ipilimumab, Nivolumab; Drug
Lead sponsor: 7 Hills Pharma, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 5
States / cities: Aurora, Colorado • Lake Mary, Florida • Lebanon, New Hampshire + 2 more

Conditions: Healthy
Interventions: Diagnostic Test: VIDAS® NEPHROCLEAR™ CCL14 Test; Device
Lead sponsor: BioMérieux; Industry
Eligibility: 21 Years and older
Enrollment: 585 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Chicago, Illinois

Conditions: Autism Spectrum Disorder
Interventions: Transdermal Neuromodulation Stimulation; Device
Lead sponsor: Phoenix Children's Hospital; Other
Eligibility: 10 Years to 25 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Head and Neck Cancer
Interventions: Radiation therapy; Radiation
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Spinal Cord Injuries
Interventions: Vibrating Dumbbell, Standard Dumbbell; Device
Lead sponsor: Alicia Koontz; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Interstitial Cystitis
Interventions: Urine stability; Other
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 16 participants
Timeline: 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Hypertensive Disorder of Pregnancy, Preeclampsia
Interventions: Treating BP acutely with intravenous or rapid acting oral medications; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Urinary Retention
Interventions: Tamsulosin; Drug
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 55 Years and older · Male only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Brick, New Jersey • Manahawkin, New Jersey • Neptune City, New Jersey + 1 more

Conditions: Major Depressive Disorder With Psychotic Features
Interventions: Quetiapine, escitalopram, Sertraline, Citalopram; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Social Determinants of Health
Interventions: 211 Referral; Behavioral
Lead sponsor: Andrea Wallace; Other
Eligibility: 18 Years and older
Enrollment: 5,081 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Thyroid Cancer
Interventions: Lenvatinib, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 38
States / cities: Little Rock, Arkansas • La Jolla, California • Los Gatos, California + 30 more

Conditions: Wound, Pressure Injury
Interventions: Standardized nursing care; Other
Lead sponsor: Regional Medical Center of San Jose; Other
Eligibility: 18 Years and older
Enrollment: 352 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Jose, California

Conditions: Bowel Preparation
Interventions: PicoPrep, HalfLytely, bisacodyl; Drug
Lead sponsor: Ferring Pharmaceuticals; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 608 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 9
States / cities: Huntsville, Alabama • Sherwood, Arkansas • Bristol, Connecticut + 6 more

Conditions: Child
Interventions: Not listed
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Colitis, Ulcerative
Interventions: Combined Anti-inflammatory Diet (CAID); Behavioral
Lead sponsor: Transparency Life Sciences; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Mechanical Ventilation
Interventions: Electronic Alerts; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Leukemia, Multiple Myeloma, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma
Interventions: Palifermin, Lupron, peripheral blood stem cell transplantation, Total-Body Irradiation (TBI), Thiotepa, Cyclophosphamide, Degarelix; Biological · Procedure · Radiation + 1 more
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: PTSD
Interventions: Equine Therapy, Therapeutic Horsemanship Program; Behavioral
Lead sponsor: VA Salt Lake City Health Care System; Federal
Eligibility: 18 Years to 70 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Suicide, Suicide, Attempted, Suicide and Self-harm, Suicide Threat
Interventions: Safe Alternatives for Teens and Youth - Parent (SAFETY-P), Treatment As Usual (TAU); Behavioral
Lead sponsor: Jennifer Hughes; Other
Eligibility: 10 Years to 18 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Columbus, Ohio

Conditions: Healthy
Interventions: morphine sulfate sustained-release capsules, KADIAN (morphine sulfate sustained-release) capsules; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Austin, Texas

Search by objective public record fields.

Abbott Atrial Fibrillation Post Approval Study

Follow-Up Study for Exubera

Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes

Embryonal Tumor With Multilayered Rosettes

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

VIDAS® NEPHROCLEAR Reference Interval Study

High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in ASD

Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

Effect of Vibration Exercise on Upper Limb Strength, Function, and Pain

Platelet Activating Factor Stability in Urine

Blood Pressure Goal in Preterm Preeclampsia

Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery

Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms

Social Needs Screenings in ED

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)

Wound Care and Pressure Injury Through the Continuum of Care

Investigation of PicoPrep Versus HalfLytely for Bowel Preparation for Colonoscopy - Split Dose PicoPrep

The Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study

Decentralized Dietary UC Pilot Trial

Titration of Oxygen Levels During Mechanical Ventilation With Electronic Alerts

Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

Equine Human Interaction With Veterans

SAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions